Yadong Yu
About Yadong Yu
Yadong Yu is a Senior Scientist with expertise in BLI/SPR kinetics assays and over 16 years of experience in protein characterization and antibody engineering. He has held positions at various institutions, including Nektar Therapeutics and UCSF, and has a PhD in Biochemistry and Molecular Biology.
Work at Nektar Therapeutics
Yadong Yu currently holds the position of Senior Scientist at Nektar Therapeutics, a role he has occupied since 2020. His work focuses on advancing scientific research and development within the organization. Nektar Therapeutics is known for its innovative approaches in drug development, particularly in the fields of immunology and oncology. Yu's expertise in protein characterization and antibody engineering contributes to the company's mission of creating novel therapeutics.
Education and Expertise
Yadong Yu has a strong educational background in the life sciences. He earned a Bachelor’s degree in Pharmaceutics from China Pharmaceutical University, where he studied from 1993 to 1997. He furthered his education by obtaining a PhD in Biochemistry and Molecular Biology from the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, from 2000 to 2005. Yu possesses 16 years of experience in protein characterization and antibody engineering, with a specific focus on BLI/SPR kinetics assays, which are essential for studying molecular interactions.
Professional Background
Yadong Yu has held various significant positions throughout his career. He worked as a Postdoctoral Scholar at the National Institutes of Health from 2005 to 2006 and later at UCSF from 2007 to 2013. Following his postdoctoral work, he served as a Research Scientist at Berkeley Lab from 2013 to 2016. He then transitioned to LakePharma, Inc. as a Senior Scientist from 2016 to 2019, and subsequently worked at Immutics as Senior Scientist II in Biophysics from 2019 to 2020 before joining Nektar Therapeutics.
Technical Contributions
In his professional roles, Yadong Yu has developed Python scripts for analyzing sequencing data of antibody libraries and screening hits. This technical contribution enhances the efficiency and accuracy of data analysis in antibody engineering projects. His skills in programming and data analysis complement his extensive knowledge in biophysics and molecular biology, making him a valuable asset in his field.